Search

Your search keyword '"Neurocysticercosis epidemiology"' showing total 361 results

Search Constraints

Start Over You searched for: Descriptor "Neurocysticercosis epidemiology" Remove constraint Descriptor: "Neurocysticercosis epidemiology"
361 results on '"Neurocysticercosis epidemiology"'

Search Results

1. Current challenges in neurocysticercosis: recent data and where we are heading.

2. Neurocysticercosis and cognitive impairment among people with epilepsy in Taenia solium endemic regions of rural southern Tanzania: A hospital-based cross-sectional study in mental health clinics of selected sites in Tanzania.

3. Socioeconomic Risk Factors in Neurocysticercosis.

4. Neurocysticercosis Prevalence and Characteristics in Communities of Sinda District in Zambia: A Cross-Sectional Study.

5. Gaps in treatment of epileptic seizures in a Zambian rural area.

6. Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis.

7. Epilepsy and neurocysticercosis in rural areas of the Bolivian Chaco: What has changed during the last 30 years?

8. Etiological Profile of First Episode Seizures in Paediatric Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study.

9. [Diagnosis of neurocysticercosis in patients with epilepsy living in the south-western Dominican Republic].

10. Monetary burden of neurocysticercosis on a hospitalized population in Muli County, China.

11. Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis Cure.

12. Why are tapeworm carriers so difficult to find? A methodological proposal for their search and recovery.

13. Knowledge and misconceptions about epilepsy among people with epilepsy and their caregivers attending mental health clinics: A qualitative study in Taenia solium endemic pig-keeping communities in Tanzania.

14. Neurocysticercosis-related seizures: Imaging biomarkers.

15. Older Age in Subarachnoid Neurocysticercosis Reflects a Long Prepatent Period.

16. Colloidal/Calcified Neurocysticercosis at University Hospital of KSA: A Case Series.

17. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe.

18. Taenia solium taeniasis/cysticercosis in Guatemala: a prevalent public health problem?

19. Diagnosing neurocysticercosis in skeletonized human remains of forensic importance.

20. Common infectious and parasitic diseases as a cause of seizures: geographic distribution and contribution to the burden of epilepsy

21. Epidemiological, clinical and radiological characteristics of people with neurocysticercosis in Tanzania-A cross-sectional study.

22. Assessing the burden of Taenia solium cysticercosis in Burundi, 2020.

23. Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries-A pooled analysis.

24. The prevalence of and contributors to neurocysticercosis in endemic regions.

25. Community-level prevalence of epilepsy and of neurocysticercosis among people with epilepsy in the Balaka district of Malawi: A cross-sectional study.

26. Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting.

27. Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries.

28. A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.

29. Neurocysticercosis control for primary epilepsy prevention: a systematic review.

30. Paediatric neurocysticercosis in high income countries.

31. [Correlation between clinical and tomographic variables in patients with neurocysticercosis. A study in a cohort of patients in Sierra Norte, Ecuador, between 2019 and 2020].

32. CystiHuman: A model of human neurocysticercosis.

33. [Epidemiology of cysticercosis in Chile].

34. Neurocysticercosis in Children.

35. Cardiac cysticercosis and neurocysticercosis in sudden and unexpected community deaths in Lusaka, Zambia: a descriptive medico-legal post-mortem examination study.

36. Human health and economic impact of neurocysticercosis in Uganda.

37. Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions.

39. Frequency and Determinant Factors for Calcification in Neurocysticercosis.

40. Incidence of Adult-Onset Epilepsy and the Contributory Role of Neurocysticercosis in a Five-Year, Population-Based, Prospective Study in Rural Ecuador.

41. Neurocysticercosis and HIV/AIDS co-infection: A scoping review.

42. Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.

43. New understanding about the relationship among neurocysticercosis, seizures, and epilepsy.

44. High frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Democratic Republic of Congo.

45. Prevalence and incidence of epilepsy in Latin America and the Caribbean: A systematic review and meta-analysis of population-based studies.

46. Neurocysticercosis in patients with active epilepsy in the tea garden community of Assam, Northeast India.

47. Recurrent Neurocysticercosis: Not So Rare.

48. Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35-55 in cerebral spinal fluid.

49. [Clinical characteristics of neurocysticercosis from a reference hospital of the northern of Peru. 2016-2018].

50. Identification of Taenia solium DNA by PCR in blood and urine samples from a tertiary care center in North India.

Catalog

Books, media, physical & digital resources